Lichtenheld MG - Search Results

1

R115777 induces Ras-independent apoptosis of myeloma cells via multiple intrinsic pathways.

Beaupre DM, Cepero E, Obeng EA, Boise LH, Lichtenheld MG. Beaupre DM, et al. Among authors: lichtenheld mg. Mol Cancer Ther. 2004 Feb;3(2):179-86. Mol Cancer Ther. 2004. PMID: 14985458

2

Farnesyl transferase inhibitors enhance death receptor signals and induce apoptosis in multiple myeloma cells.

Beaupre DM, McCafferty-Grad J, Bahlis NJ, Boise LH, Lichtenheld MG. Beaupre DM, et al. Among authors: lichtenheld mg. Leuk Lymphoma. 2003 Dec;44(12):2123-34. doi: 10.1080/1042819031000116652. Leuk Lymphoma. 2003. PMID: 14959858

3

Characterization of a R115777-resistant human multiple myeloma cell line with cross-resistance to PS-341.

Buzzeo R, Enkemann S, Nimmanapalli R, Alsina M, Lichtenheld MG, Dalton WS, Beaupre DM. Buzzeo R, et al. Among authors: lichtenheld mg. Clin Cancer Res. 2005 Aug 15;11(16):6057-64. doi: 10.1158/1078-0432.CCR-04-2685. Clin Cancer Res. 2005. PMID: 16115951

4

Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells.

Zhu K, Gerbino E, Beaupre DM, Mackley PA, Muro-Cacho C, Beam C, Hamilton AD, Lichtenheld MG, Kerr WG, Dalton W, Alsina M, Sebti SM. Zhu K, et al. Among authors: lichtenheld mg. Blood. 2005 Jun 15;105(12):4759-66. doi: 10.1182/blood-2004-11-4307. Epub 2005 Feb 22. Blood. 2005. PMID: 15728126 Free PMC article.

5

Potent inhibition of CTLA-4 expression by an anti-CTLA-4 ribozyme.

Cepero E, Hnatyszyn HJ, Kraus G, Lichtenheld MG. Cepero E, et al. Among authors: lichtenheld mg. Biochem Biophys Res Commun. 1998 Jun 29;247(3):838-43. doi: 10.1006/bbrc.1998.8889. Biochem Biophys Res Commun. 1998. PMID: 9647780 Free article.

6

Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers.

Zhang J, Scordi I, Smyth MJ, Lichtenheld MG. Zhang J, et al. Among authors: lichtenheld mg. J Exp Med. 1999 Nov 1;190(9):1297-308. doi: 10.1084/jem.190.9.1297. J Exp Med. 1999. PMID: 10544201 Free PMC article.

7

Synergy of brief activation of CD8 T-cells in the presence of IL-12 and adoptive transfer into lymphopenic hosts promotes tumor clearance and anti-tumor memory.

Díaz-Montero CM, Naga O, Zidan AA, Salem ML, Pallin M, Parmigiani A, Walker G, Wieder E, Komanduri K, Cole DJ, Montero AJ, Lichtenheld MG. Díaz-Montero CM, et al. Among authors: lichtenheld mg. Am J Cancer Res. 2011 Aug 30;1(7):882-96. Am J Cancer Res. 2011. PMID: 21915391 Free PMC article.

8

Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells.

Malek TR, Yu A, Scibelli P, Lichtenheld MG, Codias EK. Malek TR, et al. Among authors: lichtenheld mg. J Immunol. 2001 Feb 1;166(3):1675-83. doi: 10.4049/jimmunol.166.3.1675. J Immunol. 2001. PMID: 11160210

9

Non-killer cell-specific transcription factors silence the perforin promoter.

Zhang Y, Lichtenheld MG. Zhang Y, et al. Among authors: lichtenheld mg. J Immunol. 1997 Feb 15;158(4):1734-41. J Immunol. 1997. PMID: 9029110

10

A role for NF-kappa B activation in perforin expression of NK cells upon IL-2 receptor signaling.

Zhou J, Zhang J, Lichtenheld MG, Meadows GG. Zhou J, et al. Among authors: lichtenheld mg. J Immunol. 2002 Aug 1;169(3):1319-25. doi: 10.4049/jimmunol.169.3.1319. J Immunol. 2002. PMID: 12133954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page